UK Faculty of Public Health policy report on the Transatlantic Trade and Investment Partnership
Headline messages: putting profit before health
• The Transatlantic Trade and Investment Partnership (TTIP) is a comprehensive free trade agreement currently under negotiation between the EU and US
• TTIP grants the “highest levels of protection” to foreign private companies, to be enforced by secretive extra judicial tribunals (not by transparent process in domestic courts)
• TTIP grants states only weak protections against those foreign companies, threatening their right to regulate for the public benefit, and having a chilling effect on public policy
• TTIP aims to “harmonise” differences in important standards between the EU and US. This risks lowering vital health, environmental health and hard-earned workplace health and labour standards
• TTIP aims to “maximise liberalisation” of access to EU public procurement and services markets – presenting grave risks to the NHS and other public services.
Without urgent revision, TTIP poses a serious risk to health. It may increase tobacco-related harms, particularly among young people; it may increase alcohol related disorders – worsening mental health and social disruption in the community; and it may restrict governments’ ability to reduce consumption of unhealthy foods, associated with increased rates of obesity and related health outcomes. TTIP may also increase the cost of vital medicines.
FPH calls on the UK government to reject the negotiating mandate for TTIP in its entirety.